Thyrocare Technologies Limited — Regulatory Filings 2022

Nov 23, 2022

==> picture [561 x 87] intentionally omitted <==

November 23, 2022

The National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 (SYMBOL: THYROCARE)

The Bombay Stock Exchange Ltd Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001 (SCRIP CODE 539871)

Dear Sirs/Madam,

Sub: Disclosure of information under Regulation 30 of SEBI (Listing Obligations and – Disclosure Requirements) Regulations, 2015 Meeting with Investors/Analysts

--o--

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, In accordance with the said Regulations, please find below the details of meetings with Analyst/Institutional Investor:

	Date of meeting	Name of Analyst /Institutional investor /Event	Venue of the meeting	Type interaction
	November 23, 2022	GoldmanSachsServicesPrivateLimited andGoldmanSachs(India)AlternativeInvestmentManagementPrivateLimited	-	Conference call

Please note that no Unpublished Price Sensitive Information was shared during these meetings / conferences.

Yours Faithfully,

For Thyrocare Technologies Limited,

Dorai Digitally signed by Dorai Ramjee Date: 2022.11.23 Ramjee 19:36:52 +05'30'

Ramjee Dorai Company Secretary and Compliance Officer